Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.
- Published In:
- Clinical endocrinology, 95(2), 354-364 (2021)
- Authors:
- Shah, Ravikumar, Garg, Robin, Majmundar, Monil, Purandare, Nilendu, Malhotra, Gaurav, Patil, Virendra, Ramteke-Jadhav, Swati, Lila, Anurag, Shah, Nalini, Bandgar, Tushar
- Database ID:
- RPEP-05752
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05752APA
Shah, Ravikumar; Garg, Robin; Majmundar, Monil; Purandare, Nilendu; Malhotra, Gaurav; Patil, Virendra; Ramteke-Jadhav, Swati; Lila, Anurag; Shah, Nalini; Bandgar, Tushar. (2021). Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.. Clinical endocrinology, 95(2), 354-364. https://doi.org/10.1111/cen.14406
MLA
Shah, Ravikumar, et al. "Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.." Clinical endocrinology, 2021. https://doi.org/10.1111/cen.14406
RethinkPeptides
RethinkPeptides Research Database. "Exendin-4-based imaging in insulinoma localization: Systemat..." RPEP-05752. Retrieved from https://rethinkpeptides.com/research/shah-2021-exendin4based-imaging-in-insulinoma
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.